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Objective: To study the phytochemistry, anti-asthmatic and antioxidant activities of the
aqueous leaf extract of Anchomanes difformis (Blume) Engl. (A. difformis) and to verify
claims of use in folk medicine.
Methods: For anti-asthmatic activity, male and female guinea pigs with average body
weight of (451.4 ± 118.1) g were divided into six groups of six animals each. Group 1
served as control (distilled water); Group 2 was administered with salbutamol (reference
drug) only; Group 3 served as ovalbumin sensitized group, Group 4, 5 and 6 were treated
with A. difformis extract at doses of 100, 200 and 400 mg/kg, respectively. Described
methods were used to test ﬂuid viscosity, ﬂuid volume and quantitative phytochemistry
analysis. Absorbance was read using a UV–Vis spectrophotometer and results computed
in percentage. Total antioxidant assays [2, 2-diphenyl-1-picrylhydrazyl (DPPH) and lipid
peroxidation assay], were carried out using reported procedures.
Results: The anti-asthmatic evaluation showed that protection from asthma of the ani-
mals in Group 6 (400 mg/kg, 32.7%) were similar to that in Group 2 (salbutamol, 33.0%).
Excised trachea was free of mucus secretion in Group 5 (200 mg/kg) as was observed in
the control group. Fluid volume increase in Groups 3 and 6 indicated mucus secretion.
DPPH radical scavenging activity of extract was effective as ascorbic acid which served
as standard at 20 mg/mL. But, the extract elicited low lipid peroxidation activity compared
with the reference (tocopherol) at concentrations tested.
Conclusions: A. difformis aqueous leaf extract is safe and possesses positive anti-
asthmatic and antioxidant activities as claimed by traditional herbal practitioners in
Delta State.1. Introduction
Among several respiratory diseases affecting man, bronchial
asthma is the most common syndrome [1]. Asthma is currently a
worldwide problem with around 300 million people around the
globe suffering from it and world deaths of about 250 thousand
annually [2]. The universal prevalence of asthma is anticipated torange from 1% to 18%, and in Nigeria about 13% of the
populace is affected [3,4]. In developing counties, asthma is
seen in children living in the savanna region and herbal
medicine is used by over 80% of the populace to handle the
disorder [5].
Histamine is a known bronchoconstrictor which increases
airway resistance, causing difﬁculty in breathing [6]. Histamine
is an autacoid having profound physiological effect in the
body. Histamine when inhaled causes hypoxia and leads to
spasm in guinea pigs, causing very strong smooth muscle
contraction and capillary dilation in the cardiovascular system.
However, bronchodilators can delay the onset of these
symptoms [7–10]. Histamine tightens the trachea–bronchial
muscle of guinea pigs, goat, horse, dog and man [11]. The
anaphylactic sensitization and close semblance of pulmonary
reaction to histamine in both guinea pigs and humans make
guinea pig the choice for model species [12].rticle under the CC BY-NC-ND license (http://
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terns of symptoms and physical examination. The gold standard
for the diagnosis of asthma is spirometry, showing > 12 per cent
and > 200 mL improvement in forced expiratory volume in 1 s
after bronchodilation [13]. Asthma is classiﬁed according to
continue symptoms and their severity [13]. Five to ten percent
of the asthma population experience more severe forms of the
disease, which remain symptomatic despite high doses of
conventional inhaled and oral anti-inﬂammatory drugs [14].
This represents a small subset of the total population of
asthma sufferers, but severe asthmatics account for nearly half
the total healthcare costs associated with the disease, and
majority of asthma-related deaths [15,16].
Exposure to common allergens and indoor and outdoor air
pollution from various sources (e.g., trafﬁc pollution, second
hand tobacco smoking, combustion of fossils and biomass fuels,
workplace dust) has acted as trigger of the disease [17–19]. Viral
infections, a major cause of upper respiratory tract infections,
and common cold are also common risk factors in children
[20,21]. Reactive oxygen species are associated with the
pathogenesis of asthma by evoking bronchial hyper-reactivity
and stimulating histamine release from mast cells and mucus
secretion from airway epithelial cells [22].
Free radicals are causative agents of several diseases
including bronchial asthma. Free oxygen radicals can cause
wide spread damage of all biological membranes by
attacking their protein, lipids, nucleic acids and glyco-
conjugates [9]. Natural antioxidants can protect the human
body from free radicals; retard the progress of many
chronic diseases and lipid oxidative rancidity in foods or
medicinal materials [23].
Phytochemical studies are of interest to plant scientists due
to new and sophisticated drug discoveries [24]. Plant
synthesizes a wide variety of chemical compounds, which
can be sorted by their chemical class, biosynthetic origin and
functional groups into primary and secondary metabolites
[24]. Medicinal value of these plants lies in some chemical
substances that produce deﬁnite physiological action on the
human body [25]. Most important of these bioactive
constituents of plants are alkaloids, tannins, ﬂavonoids and
phenolic compounds [26]. Secondary metabolites are diverse
compounds with obscure roles. They are used in the human
therapy, veterinary, agriculture, scientiﬁc research and
countless others [27,28]. Phytochemicals can be derived from
barks, leaves, ﬂowers, roots, fruits and seeds [29]. Knowledge
of the chemical constituents of plants is desirable, not just for
the discovery of therapeutic agents, but also because such
information is of value in disclosing new resources of such
chemicals [30].
Anchomanes difformis (A. difformis) is a plant with many
reported therapeutic values [31–34]. Idu et al. reported the
extensive use of A. difformis in treating asthma by traditional
herbal practitioners of Udu and Ughievwen clans of Delta
State [35]. However, there's no scientiﬁc data available to
justify this claim. This study was aimed at investigating the
anti-asthmatic property of the aqueous leaf extract of
A. difformis, assessing its effect on histamine-induced bron-
chospasm, tracheal ﬂuid viscosity and ﬂuid volume using guinea
pigs. The phytochemical constituents and the antioxidant ac-
tivities of the extract of A. difformis were also experimented.2. Materials and methods
2.1. Plant materials and preparation of extract
Fresh leaves of A. difformis were collected from a bush in
Ekosodin Village, Ovia North East local government area of Edo
State. The plant was authenticated by Professor MacDonald Idu
of the Department of Plant Biology and Biotechnology, Uni-
versity of Benin, Benin City. The leaves were washed in distilled
water and blended using a kitchen blender. Mixture of blended
leaves was drained using a muslin cloth. Leaf particles were
discarded. Filtrate was concentrated to dryness using an FD-
10M freeze dryer at −4 C for two days in the National Centre
for Energy and Environment, Energy Commission of Nigeria,
Benin City, Nigeria.2.2. Experimental animals
Adult guinea pigs of both sexes weighing (451.4 ± 18.1) g
(mean ± SEM) were got from the livestock market, Aduwawa,
Benin City. They were acclimatized for two weeks in the Animal
House of the Department of Animal and Environmental
Biology, University of Benin, Benin City, Nigeria. The animals
were fed with grower mash and Elephant grass (Pennisetum
purpureum) with access to drinking water ad libitum. Procedures
on animal use and ethics were adhered to throughout this
experiment.2.3. Anti-asthmatic experiment
After two weeks of acclimatization, the guinea pigs were
randomized into 6 groups (n = 6 per group) and were orally
administered for 7 consecutive days with A. difformis aqueous
leaf extract or agents. The groups are Group 1: non-sensitized
control administered with 2 mL/kg distilled water per day;
Group 2: ovalbumin (OA) sensitized followed by 2 mL/kg per
day distilled water; Group 3: OA sensitized followed by
100 mg/kg/day A. difformis extract; Group 4: OA sensitized
followed by 200 mg/kg/day A. difformis extract; Group 5: OA
sensitized followed by 400 mg/kg/day A. difformis extract;
Group 6: OA sensitized followed by 0.5 mg/kg/day
salbutamol.
The animals were sensitized by administering 100 mg/kg
OA intraperitoneal on the ﬁrst day and a booster dose of 50 mg/
kg intramuscular 24 h afterward. The animals were fasted
overnight on the 6th day. On the 7th day, all six groups of
animals were exposed to 0.2% histamine aerosol (Omron®
compressor nebulizer, USA) under a mean pressure of
(280 ± 5) mmHg till the ﬁrst signs of pre-convulsive breathing
was observed at a rate of 0.4 mL/min with particle size of 5 mm
in a glass chamber (60 cm × 36 cm × 60 cm). The latency to
pre-convulsive dyspnea which was the time from aerosol
exposure to the onset of pre-convulsive dyspnea was recorded
for each animal [12]. Drug administration was via the oral route
one hour before challenge. Percentage protection from
convulsion was expressed relative to control. Guinea pigs
from control and extract-adapted groups were sacriﬁced and
2 cm of their trachea excised for tracheal ﬂuid volume and
viscosity examination.
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pigs
Histamine when inhaled induces bronchoconstriction by
direct H1 receptor activation. Histamine when inhaled shows
hypoxia and leads to convulsion in guinea pigs. This model
screens the effect of A. difformis aqueous extract on histamine
induced bronchoconstriction by measuring time required for pre-
convulsive dyspnea caused by histamine aerosol to manifest [36].
2.5. Evaluation of tracheal ﬂuid volume
After exposure to histamine aerosol, the animals were
anaesthetized using 2% chloroform. While unconscious, the
guinea pigs were dissected and their tracheas were isolated.
Using a syringe, 2 mL of chilled distilled water and air was
passed through the trachea to make it mucus/ﬂuid free. The
trachea ﬂuid volume was determined by subtracting 2 mL
(volume of distilled water) from the overall ﬂuid volume. The
resulting value represented the volume of the mucus in the
trachea.
2.6. Evaluation of tracheal ﬂuid viscosity
A retort stand with a syringe holding the tracheal ﬂuid vol-
ume was set up. The stopper was removed and the time taken for
the ﬂuid to run off the syringe was recorded. The test groups and
control group was statistically compared. The idea was to see if
the ﬂuid was slimy or clear as water.
2.7. Antioxidant assays
2.7.1. Determination of 2,2-diphenyl-1-picrylhydrazyl
(DPPH) radical scavenging activity
Five milligrams of the crude extract were dissolved in 20 mL
of distilled water. DPPH (1 mL) was mixed with 0.5 mL of the
extract. The solution was stood in the dark at room temperature
for 30 min and thereafter read on the UV at a wavelength of
517 nm. Standard drug was ascorbic acid.
% DPPH free radical was calculated using 100 × (1 − AE/
AD), where, AE is the absorbance of the sample solution; AD is
the absorbance of blank.
2.7.2. Determination of lipid peroxidation
Lipid peroxidation was determined using thiobarbituric acid
reactive substance assay. A. difformis aqueous leaf extract
(0.5 mL) was mixed with 2 mL of thiobarbituric acid reagent
containing 0.375% thiobarbituric acid, 15% trichloroacetic acid
and 0.25 mol/L HCl. Samples were heated for 15 min, cooled
and centrifuged. Absorbances of the supernatants were read at
532 nm using a spectrophotometer. A thiobarbituric acid reac-
tive substance concentration was calculated by the use of
1,1,3,3-tetramethoxypropane as an external standard with results
presented as nmol methane dicarboxylic aldehyde equivalent
formed/mg protein at 37 C [37].
2.8. Phytochemistry
2.8.1. Determination of total phenols
Crude extract please was heated with 50 mL of ether to
extract the phenolic components for 15 min. A volume of 5 mLextract was pipetted into 50 mL ﬂask with additional 10 mL of
distilled water, 2 mL of ammonium hydroxide solution and
5 mL of concentrated amyl alcohol. The sample was left to react
for 30 min for color development. Result was read at 505 nm.
2.8.2. Determination of alkaloid
Five grams of extract was mixed with 200 mL of 10% acetic
acid in ethanol and allowed to stand for 4 h. Mixture was sieved
and the extract was concentrated on a water bath to one quarter
of the original volume. Concentrated ammonium hydroxide was
introduced drop wise to extract until precipitate was complete.
The whole solution was settled and the precipitate was washed
with dilute ammonium hydroxide and then ﬁltered. The residue
which was the alkaloid was desiccated and weighed [38].
2.8.3. Determination of tannin
Five hundred milligram of extract was poured into 50 mL of
distilled water and shaken for 1 h in a mechanical shaker and
strained into a 50 mL volumetric ﬂask. Five milliliters of the
ﬁltered was pipetted out into a test tube and mixed with 2 mL of
0.1 mol/L FeCl3 in 0.1 mol/L HCl and 0.008 mol/L potassium
ferrocyanide. Absorbance was read at 120 nm within 10 min [38].
2.8.4. Determination of saponins
Dried leaves of A. difformis were ground and 20 g of each
was put into a conical ﬂask and 100 mL of 20% aqueous ethanol
was added. Mixture was heated over a hot water bath for 4 h
with continuous stirring at about 55 C, then ﬁltered. The res-
idue was re-extracted with 200 mL 20% ethanol. Both ﬁltrates
were concentrated over a water bath at 90 C. The concentrate
was poured into a 250 mL separatory funnel and 20 mL of
diethyl ether was added and shaken. Aqueous layer was recu-
perated while the ether layer discarded. A total of 60 mL of n-
butanol was added. The combined n-butanol extracts were
washed twice with 10 mL of 5% aqueous sodium chloride. The
remaining solution was heated in a water bath. After evapora-
tion, the samples were dried in the oven to a constant weight.
The saponins content was calculated in percentage [39].
2.8.5. Determination of ﬂavonoids
The plant sample (10 g) was soaked in 100 mL of water at
room temperature. The mix was ﬁltered through Whatman ﬁlter
paper No. 42 (125 mm). The ﬁltrate was evaporated to dryness
over a water bath and weighed to a constant weight in a crucible.
2.8.6. Determination of terpenoids
About 0.1 g sample was poured into 40 mL of distilled water
and put in an oven at 100 C for 15 min. The supernatant was
drained and centrifuged then re-extracted with 5 mL petroleum
ether. The absorbance was read at 450 nm.
2.8.7. Determination of anthraquinones
A total of 50 mg of the ground leaf sample was weighed. A
volume of 50 mL of distilled water was added and allowed to
stand for 15 min. Thereafter, mixture was heat at 70 C for 1 h
and cooled and ﬁltered. The clear solution was read at 450 nm.
2.9. Statistical analysis
The results are presented as mean ± SEM (standard error of
mean) and n represents the number of animals used in each
Figure 2. Fluid volume of guinea pig trachea after 7 days administration
with 100, 200, and 400 mg/kg A. difformis extract.
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ANOVA and multiple comparisons using Graph pad computer
software version 6.0. P < 0.05 shows signiﬁcant difference.
Percentage protection from asthma i.e. Latency to pre-
convulsive dyspnea (PCD) was calculated using (1 − T1/
T2) × 100. Where, T1 represents Latency to pre-convulsive
dyspnea after acute administration (Day 0), while T2 repre-
sents Latency to pre-convulsive dyspnea after sub-acute
administration (Day 7). The difference between T1 and T2 was
used as a measure of determining the anti-asthmatic activities of
A. difformis.
3. Results
The results of the effects of a single dose and repeated dose
(7 days) of aqueous leaf extract of A. difformis on guinea pigs
exposed to 0.2% histamine aerosol in a nebulizer machine
chamber are reported in Table 1. Percentage protection from
asthma was not signiﬁcantly different between the reference
drug salbutamol (32.5%) and aqueous leaf extract of A. difformis
at 400 mg/kg (32.7%).Table 1
Effect of aqueous leaf extract of A. difformis on guinea pigs broncho-
constriction induced by histamine.
Group Dose
(mg/kg)
Latency period to
convulsion (s)
% Protection
Day 0 Day 7
Control
(distilled
water)
2 p.o. 93.0 ± 0.5 90.0 ± 0.57 –
Standard
salbutamol
0.5 p.o. 92.5 ± 0.3 137.0 ± 0.61** 32.5
Sensitized
ovalbumin
100 i.p.,
50 i.m.
46.6 ± 0.6 54.6 ± 0.8*** 15.0
Aqueous
extract of
A. difformis
100 67.6 ± 0.5* 86.5 ± 0.34 22.0
200 78.5 ± 0.4* 104.0 ± 0.58** 24.5
400 90.5 ± 0.5** 133.0 ± 0.44** 32.7
Values are presented as mean ± SEM, n = 5. ***: P < 0.001, **: P < 0.01
and *: P < 0.05 signiﬁcance against control.
Figure 3. Total antioxidant (DPPH) assay using A. difformis Blume
aqueous leaf extract.The ﬂuid viscosity of air and water passed through the res-
piratory tracts (trachea) of guinea pigs is shown in Figure 1. Also
the ﬂuid volume i.e. mucus content in the trachea is shown in
Figure 2 below.Figure 1. Fluid viscosity of 2 cm excised guinea pig trachea after 7 days
administration with 100, 200, and 400 mg/kg A. difformis extract.Trachea was observed to have less mucus secretions at
100 mg/kg and 200 mg/kg as compared to other groups
including the group administered the reference drug
(salbutamol).
Excess ﬂuid volume was observed in the trachea of animals
in the sensitized group and those treated with 400 mg/kg of
A. difformis leaf extract as displayed in Figure 2.
Figures 3 and 4 show the results of the antioxidant activities
of A. difformis as against standard antioxidants. A. difformisFigure 4. Lipid peroxidation (antioxidant assay) using A. difformis
aqueous leaf extract.
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drug (ascorbic acid) at 20 mg/mL but showed no lipid peroxi-
dation activities at concentrations tested.
Table 2 shows the phytochemistry results of A. difformis
aqueous leaf extract and the relative abundance of some tested
phytochemicals. Flavonoids and steroids are the most abundant
phytochemicals present in the extract.Table 2
Quantitative phytochemistry of A. difformis aqueous leaf extract. %.
Phytochemicals Percentage yield
Tannins 0.66 ± 0.04
Saponins 0.13 ± 0.10
Flavonoids 1.60 ± 0.11
Alkaloids 1.26 ± 0.12
Phenols 0.74 ± 0.10
Terpenoids 0.17 ± 0.05
Steroids 1.76 ± 0.05
Cardiac glycosides 0.00 ± 0.00
Anthraquinone 0.00 ± 0.00
Values are expressed as mean ± SEM, n = 3.4. Discussion
Traditional medicine practitioners have recommended
several plants to treat asthma and other allergic disorders which
have been successful in controlling the disease [40]. Some
medicinal plant preparations possess bronchodilatory effects
such as Bryophyllum pinnatum [41]. The present study resulted
in deep-rooting the bronchodilator properties of A. difformis,
justifying its traditional claim in handling asthma [35].
The disorder of bronchial asthma is characterized by wide
narrowing of the bronchial tube due to contraction of smooth
muscle in response to stimuli causing the release of chemical
mediators such as histamine [42,43]. Although results in this
study show the anti-asthmatic, acute and sub-acute (Table 1)
activities of A. difformis aqueous leaf exact, the mechanism of
action could not be conﬁrmed in this study. The trachea ﬂuid
viscosity and ﬂuid volume test results (Figures 1 and 2) show
that there are no statistical differences (P > 0.05) between the
test groups and control group.
Phytoconstituents like alkaloids and ﬂavonoids are attributed
to possess bronchodilatory activity [44]. In literature, most drugs
that have been effective in managing asthma are rich in
steroidal components [45]. A. difformis contains steroids
(1.76% ± 0.05%), ﬂavonoids (1.60% ± 0.11%) and alkaloids
(1.26% ± 0.12%) as reported in Table 2. Flavonoids possess
antioxidant properties which may underlie their effectiveness in
asthma management [46,47]. Natural antioxidants in the form of
ﬂavonoids can impair Ca2+ release and the utilization
mechanisms in smooth muscles and can be used for the
treatment of degenerative diseases [48,49]. In addition,
ﬂavonoids inhibit antigen-induced release of histamine from
mast cells, basophils and also inhibit contractions induced by
histamine, acetylcholine and phosphodiesterase [50]. Flavonoids
are reported to inhibit phospholipid metabolism through the 5-
lipoxygenase pathway, inhibiting the products of 5-lip-
oxygenase that mediate constriction of airway smooth muscle
[51]. Constituents of A. difformis such as ﬂavonoids and ascorbic
acid are natural anti-oxidants which can prevent cell damage and
the pathological consequences [41]. These constituents may havebeen responsible for the many ethnomedicinal uses of the plant.
For example, ﬂavonoids as water-soluble antioxidants are free
radical scavengers which thwart oxidative cell injury showing
good anticancer properties [48].
The cells inﬁltrating the bronchial mucosa in patients with
asthma produce reactive oxygen species [52]. Oxidative damage
represents dynamic balance between a degree of oxidative
damage and repair of this damage. Increased oxidative damage
can contribute to the origin and development of respiratory
disease including bronchial asthma. Vitamin C (ascorbic acid)
is a water soluble antioxidant present physiologically in the
airway and alveolar lining ﬂuid. Its function is to counter both
exogenous and endogenous sources of oxidation [53]. Vitamin C
plays a role in quenching reactive oxygen species to counteract
reactive oxygen species effect and render them harmless [54].
Ascorbate prevents lipid peroxidation through its reaction with
membrane a-tocopherol and lowers tocopherol radical
concentration by rejuvenating its non-radical form thus,
restoring its scavenging activity and preventing lipid peroxidation.
The DPPH and lipid peroxidase antioxidant assays carried
out in this research (Figures 3 and 4) tells that the plant portends
antioxidant activities. Abubakar et al. reported that the meth-
anol, acetone and n-butanol extracts of A. difformis showed
signiﬁcant free radical scavenging (DPPH) activity with n-
butanol extract showing highest activity at concentrations of
31.25% and 62.5% [55]. This was perhaps so because all three
solvents except methanol are bipolar solvents unlike water
which is a universal solvent. However, the total antioxidant
assay results in this study showed that the aqueous leaf extract
of A. difformis exerted equal antioxidant properties as ascorbic
acid which served as the test standard at 20 mg/mL. Lipid
peroxidase assay shows that the extract has a poor antioxidant
activity as against the standard test, a-tocopherol (Figure 4).
The DPPH test provides information on the reactivity of the test
compounds with a stable free radical [56]. DPPH gives strong
absorption band at 517 nm in the visible light region. When
the odd electron become paired off in a free radical scavenger,
the absorption drops and the DPPH solution is decolourized as
the color changes from deep violet to light yellow. The result
of the DPPH antioxidant assay in this study corroborates with
the antioxidant assay reports of Idowu et al. who reported
appreciable antioxidant activity of A. difformis ethanol extract
[56]. The comparison here is for the reason that ethanol and
water are both polar solvents.
This study afﬁrms the claims of the use of A. difformis in
managing asthma by traditional herbal practitioners of Udu and
Ughievwen clans of Delta State. This study also showed that
animals treated with A. difformis extract before exposure to
histamine had no mucus secretion in their trachea. A. difformis
has a good DPPH radical scavenging activity and contains
phytochemicals relevant in handling asthma.
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